Cargando…
Colon Cancer Pharmacogenetics: A Narrative Review
Currently, metastatic colon cancer is treated with monotherapeutic regimens such as folinic acid, fluorouracil, and oxaliplatin (FOLFOX), capecitabine and oxaliplatin (CapeOX), and leucovorin, fluorouracil, and irinotecan hydrochloride (FOLFIRI). Other treatments include biological therapies and imm...
Autores principales: | Alfaro Alfaro, Álvaro Esteban, Murillo Castillo, Brayan, Cordero García, Eugenia, Tascón, Javier, Morales, Ana I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413567/ https://www.ncbi.nlm.nih.gov/pubmed/36005935 http://dx.doi.org/10.3390/pharmacy10040095 |
Ejemplares similares
-
Metformin and breast cancer: an opportunity for pharmacogenetics
por: Cuyàs, Elisabet, et al.
Publicado: (2022) -
Insight into Risk Factors, Pharmacogenetics/Genomics, and Management of Adverse Drug Reactions in Elderly: A Narrative Review
por: Bellanca, Carlo Maria, et al.
Publicado: (2023) -
Pharmacogenetics of Pediatric Asthma: Current Perspectives
por: Perez-Garcia, Javier, et al.
Publicado: (2020) -
Pharmacogenetics Update on Biologic Therapy in Psoriasis
por: Muñoz-Aceituno, Ester, et al.
Publicado: (2020) -
Genetics of Psoriasis and Pharmacogenetics of Biological Drugs
por: Prieto-Pérez, Rocío, et al.
Publicado: (2013)